Detalhe da pesquisa
1.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111658
2.
Association of Cytogenetics Aberrations and IGHV Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting.
Glob Med Genet
; 11(1): 59-68, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348157
3.
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.
Cancer Med
; 12(14): 14892-14901, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212507
4.
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.
Cancers (Basel)
; 14(9)2022 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565471
5.
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.
Cancers (Basel)
; 14(7)2022 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406512
6.
Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
Hum Vaccin Immunother
; 17(12): 5129-5132, 2021 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34920695
7.
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
Clin Lymphoma Myeloma Leuk
; 21(10): e801-e809, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376375
8.
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
Leuk Lymphoma
; 62(12): 2928-2938, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292118
9.
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
Blood Cancer J
; 11(2): 21, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563901
10.
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Leukemia
; 35(2): 485-493, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414483
11.
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.
Biomed Res Int
; 2018: 9506979, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736400
12.
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Leuk Lymphoma
; 59(5): 1113-1120, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838276
13.
Breakthrough infections in MPN-COVID vaccinated patients.
Blood Cancer J
; 12(11): 154, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379921
14.
Second versus first wave of COVID-19 in patients with MPN.
Leukemia
; 36(3): 897-900, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064223
15.
COVID-19 in patients with hematological malignancies: A retrospective case series.
Int J Lab Hematol
; 42(6): e256-e259, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749757
16.
Plasmablastic lymphoma associated to Crohn's disease and hepatitis C virus chronic infection.
J Crohns Colitis
; 5(6): 628-32, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22115386
17.
Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.
Eur J Dermatol
; 25(6): 622-3, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26552844